Literature DB >> 33993164

Nugent Score, Amsel's Criteria, and a Point-of-Care Rapid Test for Diagnosis of Bacterial Vaginosis: Performance in a Cohort of Kenyan Women.

Erica M Lokken, Clayton Jisuvei1, Brenda Oyaro2, Juma Shafi2, Maureen Nyaigero1, John Kinuthia, Kishor Mandaliya3, Walter Jaoko2, R Scott McClelland.   

Abstract

ABSTRACT: There are minimal data on the BVBlue test for diagnosis of bacterial vaginosis (BV) in Africa. Among 701 Kenyan women, compared with Nugent score ≥7, the BVBlue test had moderate sensitivity (81.9%; 95% confidence interval, 76.5%-86.5%) and high specificity (92.4%; 95% confidence interval, 89.5%-94.6%). This test may provide a complimentary approach to syndromic management.
Copyright © 2021 American Sexually Transmitted Diseases Association. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 33993164      PMCID: PMC8590706          DOI: 10.1097/OLQ.0000000000001469

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  15 in total

Review 1.  Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective.

Authors:  Rebecca M Brotman
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

2.  Sexually transmitted infections among African women: an opportunity for combination sexually transmitted infection/HIV prevention.

Authors:  Jenell Stewart; Elizabeth Bukusi; Connie Celum; Sinead Delany-Moretlwe; Jared M Baeten
Journal:  AIDS       Date:  2020-04-01       Impact factor: 4.177

3.  Elevated Risk of Bacterial Vaginosis Among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study.

Authors:  Kathryn Peebles; Flavia M Kiweewa; Thesla Palanee-Phillips; Catherine Chappell; Devika Singh; Katherine E Bunge; Logashvari Naidoo; Bonus Makanani; Nitesha Jeenarain; Doerieyah Reynolds; Sharon L Hillier; Elizabeth R Brown; Jared M Baeten; Jennifer E Balkus
Journal:  Clin Infect Dis       Date:  2021-08-02       Impact factor: 9.079

4.  Targeted point-of-care testing compared with syndromic management of urogenital infections in women (WISH): a cross-sectional screening and diagnostic accuracy study.

Authors:  Marijn C Verwijs; Stephen K Agaba; Jean-Claude Sumanyi; Marie Michele Umulisa; Lambert Mwambarangwe; Viateur Musengamana; Mireille Uwineza; Vicky Cuylaerts; Tania Crucitti; Vicky Jespers; Janneke H H M van de Wijgert
Journal:  Lancet Infect Dis       Date:  2019-04-25       Impact factor: 25.071

5.  Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora.

Authors:  A M Briselden; B J Moncla; C E Stevens; S L Hillier
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

6.  Evaluation of BV(®) Blue Test Kit for the diagnosis of bacterial vaginosis.

Authors:  Nirmala Chandralega Kampan; Seri Suniza Suffian; Nur Suhaini Ithnin; Marlyn Muhammad; Syed Zulkifli Syed Zakaria; Muhammad Abdul Jamil
Journal:  Sex Reprod Healthc       Date:  2010-11-18

7.  Immunoglobulin A response against Gardnerella vaginalis hemolysin and sialidase activity in bacterial vaginosis.

Authors:  S Cauci; S Driussi; R Monte; P Lanzafame; E Pitzus; F Quadrifoglio
Journal:  Am J Obstet Gynecol       Date:  1998-03       Impact factor: 8.661

8.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

Review 9.  Molecular Diagnosis of Bacterial Vaginosis: an Update.

Authors:  Jenell S Coleman; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

10.  Performance of BVBlue rapid test in detecting bacterial vaginosis among women in Mysore, India.

Authors:  Purnima Madhivanan; Karl Krupp; Tan Li; Kavitha Ravi; Julia Selezneva; Vijaya Srinivas; Anjali Arun; Jeffrey D Klausner
Journal:  Infect Dis Obstet Gynecol       Date:  2014-01-12
View more
  1 in total

1.  Influence of Lacidophilin Vaginal Capsules plus rh-IFN-α2b on Efficacy, Vaginal Microecology, and Safety of Patients with HPV Infection.

Authors:  Yan Sun; Jianqun Xu; Hongya Zhou; Lina You; Yan Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-03       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.